{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"408"},{"groupId":"OG001","value":"90"},{"groupId":"OG002","value":"380"},{"groupId":"OG003","value":"117"}],"title":"Alive"},{"measurements":[{"groupId":"OG000","value":"511"},{"groupId":"OG001","value":"265"},{"groupId":"OG002","value":"452"},{"groupId":"OG003","value":"323"}],"title":"Dead"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"919"},{"groupId":"OG001","value":"355"},{"groupId":"OG002","value":"832"},{"groupId":"OG003","value":"440"}],"units":"Participants"}],"description":"The time alive in months from study entry to last contact or death.","groups":[{"description":"Patients with estrogen receptor positive tumors","id":"OG000","title":"Estrogen Receptor Positive"},{"description":"Patients with estrogen receptor negative tumors","id":"OG001","title":"Estrogen Receptor Negative"},{"description":"Patients with progesterone receptor positive tumors","id":"OG002","title":"Progesterone Receptor Positive"},{"description":"Patients with progesterone receptor negative tumors","id":"OG003","title":"Progesterone Receptor Negative"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Eligible patients with estrogen and progesterone receptor data.","reportingStatus":"POSTED","timeFrame":"Patients were assessed during treatment. Following completion of treatment, follow up was assessed every 3 months for 2 years, then every 6 months for 3 years and annually thereafter, for a maximum of 10 years.","title":"Number of Participants Alive at Time of Last Follow-up by Estrogen or Progesterone Receptor Status (Positive or Negative)","type":"SECONDARY","unitOfMeasure":"Participants"}